| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/14/2001 | EP1083222A2 Endo-xyloglucan transferase |
| 03/14/2001 | EP1083177A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same |
| 03/14/2001 | EP1082875A1 Improved brush block housing for propeller deicing system |
| 03/14/2001 | EP1082591A1 Sensing tapes for strain and/or temperature sensing |
| 03/14/2001 | EP1082466A1 Method, reagent and kit for genotyping of human papillomavirus |
| 03/14/2001 | EP1082465A2 Method for detecting microorganisms in products |
| 03/14/2001 | EP1082463A1 Mechanical stress induced genes, expression products therefrom, and uses thereof |
| 03/14/2001 | EP1082462A1 Identification of molecular interaction sites in rna for novel drug discovery |
| 03/14/2001 | EP1082461A1 Method for amplifying at least a particular nucleotide sequence and primers used |
| 03/14/2001 | EP1082460A1 A novel method of diagnosing, monitoring, and staging prostate cancer |
| 03/14/2001 | EP1082459A1 A novel method of diagnosing, monitoring, and staging lung cancer |
| 03/14/2001 | EP1082458A1 Method of determining the nucleotide sequence of oligonucleotides and dna molecules |
| 03/14/2001 | EP1082457A2 Nucleic acid encoding rate agouti related protein |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082455A1 Primers for the detection of spore forming bacteria in paper products and paper manufacturing streams |
| 03/14/2001 | EP1082454A1 Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy |
| 03/14/2001 | EP1082447A2 Lentiviral vectors, comprising modified major donor splice sites and major packaging singals |
| 03/14/2001 | EP1082446A1 Recombinant aav vectors for gene therapy of hemophilia a |
| 03/14/2001 | EP1082445A2 Adeno-associated viral vector-mediated expression of factor viii activity |
| 03/14/2001 | EP1082444A1 Adeno-associated virus vectors and uses thereof |
| 03/14/2001 | EP1082443A1 Serine protease variants having amino acid deletions and substitutions |
| 03/14/2001 | EP1082442A1 Serine protease variants having amino acid substitutions |
| 03/14/2001 | EP1082441A1 Mycobacterial n-acetyltransferases |
| 03/14/2001 | EP1082440A1 LIPOPOLYSACCHARIDE $g(a)-2,3 SIALYLTRANSFERASE OF $i(CAMPYLOBACTER JEJUNI) AND ITS USES |
| 03/14/2001 | EP1082439A2 Recombinant narbonolide polyketide synthase |
| 03/14/2001 | EP1082438A2 Genetic method for producing riboflavin |
| 03/14/2001 | EP1082437A1 Xenobiotic related induction of gene expression |
| 03/14/2001 | EP1082435A2 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 03/14/2001 | EP1082434A1 NOVEL INSECTICIDAL TOXINS FROM $i(XENORHABDUS NEMATOPHILUS) AND NUCLEIC ACID SEQUENCES CODING THEREFOR |
| 03/14/2001 | EP1082433A1 Interleukins-21 and 22 |
| 03/14/2001 | EP1082432A2 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 03/14/2001 | EP1082431A2 Protease inhibitor peptides |
| 03/14/2001 | EP1082430A1 Kunitz domain polypeptide and materials and methods for making it |
| 03/14/2001 | EP1082429A2 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY |
| 03/14/2001 | EP1082428A2 Inhibition of viral infection and spread with viral and rhoa-derived peptides |
| 03/14/2001 | EP1082427A2 Insulin-like growth factor binding protein-3 variants |
| 03/14/2001 | EP1082426A2 Human socs proteins |
| 03/14/2001 | EP1082425A2 Ion channels |
| 03/14/2001 | EP1082424A1 Tumor suppressor |
| 03/14/2001 | EP1082423A1 Cyclin e2 genes and proteins |
| 03/14/2001 | EP1082422A2 Polypeptides from creb binding protein and related protein p300 for use in transcriptional regulation |
| 03/14/2001 | EP1082421A2 Human bmp-2 promoter and method for exploring bone-related substance by using the same |
| 03/14/2001 | EP1082420A2 Human nucleic acid sequences from normal pancreas tissue |
| 03/14/2001 | EP1082419A2 Combination therapy using nucleic acids and conventional drugs |
| 03/14/2001 | EP1082418A2 Combination therapy using nucleic acids and radio therapy |
| 03/14/2001 | EP1082417A1 Phenotype modifying genetic sequences |
| 03/14/2001 | EP1082416A2 Poly(adp-ribose)polymerase gene |
| 03/14/2001 | EP1082415A1 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/14/2001 | EP1082413A2 Aav5 vector and uses thereof |
| 03/14/2001 | EP1082409A1 RESISTANCE IN PLANTS TO INFECTION BY ssDNA VIRUS USING INOVIRIDAE VIRUS ssDNA-BINDING PROTEIN, COMPOSITIONS AND METHODS OF USE |
| 03/14/2001 | EP1082408A1 Irak modified transgenic animals |
| 03/14/2001 | EP1082404A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions |
| 03/14/2001 | EP1082346A1 Specific binding proteins for treating canine allergy |
| 03/14/2001 | EP1082344A2 Glycoproteins having lipid mobilising properties and therapeutic applications thereof |
| 03/14/2001 | EP1082341A2 Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
| 03/14/2001 | EP1082336A2 Apoptosis modulators that interact with the huntington's disease gene |
| 03/14/2001 | EP1082335A1 Novel secreted and membrane-associated proteins and uses therefor |
| 03/14/2001 | EP1082334A1 Alg-2lp, alg-2 like molecules and uses therefor |
| 03/14/2001 | EP1082332A1 Silica-guanidiniumthiocyanate dna isolation using casein |
| 03/14/2001 | EP1082238A1 Reinforced beam assembly |
| 03/14/2001 | EP1082142A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 03/14/2001 | EP1082141A1 Cd40 binding molecules and ctl peptides for treating tumors |
| 03/14/2001 | EP1082136A1 The cytokine family member, 2-19 |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP0987936A4 Fatty acid desaturases and mutant sequences thereof |
| 03/14/2001 | EP0975427B1 A device for performing an assay, use of a membrane in the manufacture of said device, kit comprising said device and method for the detection of an analyte using such device. |
| 03/14/2001 | EP0804601B1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
| 03/14/2001 | EP0671472B1 Anti-feline herpesvirus-1 recombinant antibody and gene fragment coding for said antibody |
| 03/14/2001 | EP0640143B1 Senescent cell derived inhibitors of dna synthesis |
| 03/14/2001 | EP0638089B1 Synthesis of diverse and useful collections of oligonucleotides |
| 03/14/2001 | EP0584279B1 Targeted delivery of genes encoding immunogenic proteins |
| 03/14/2001 | EP0569527B1 Inherited and somatic mutations of apc gene in colorectal cancer of humans |
| 03/14/2001 | CN1287689A Affinity based self-assembly systems and devices for photonic and electronic applications |
| 03/14/2001 | CN1287641A Method and apparatus for performing pattern dictionary formation for use in sequence homology detection |
| 03/14/2001 | CN1287574A Genes expressed in human monocytes and human macrophages |
| 03/14/2001 | CN1287492A Method for administering ASPB 28-human insulin |
| 03/14/2001 | CN1287491A Method for administering monomeric insulin analogs |
| 03/14/2001 | CN1287177A Method of screening genovariant and protein combining DNA segment |
| 03/14/2001 | CN1287174A Recombined new thrombolytic enzyme |
| 03/14/2001 | CN1287173A Human 3-phosphoserine transferase and its code sequence, preparation and application |
| 03/14/2001 | CN1287172A Human uridine kinase and its code sequence, preparation and application |
| 03/14/2001 | CN1287171A Human neuron calcium sensing protein and its code sequence, preparation and use |
| 03/14/2001 | CN1287170A New human nerve mass-transferring protein and its code sequence |
| 03/14/2001 | CN1287169A New human G protein protomer and its code sequence |
| 03/14/2001 | CN1287168A New human hair protein and its sequence |
| 03/14/2001 | CN1287166A Separation, extracorporeal culture, preparation and application of human primitive mesenchymal stem cell population |
| 03/14/2001 | CN1287124A Recombined natural and new-type human insulin and its preparation |
| 03/14/2001 | CN1063265C Electrophoresis process for transfering a large molecular nuleic acid |
| 03/14/2001 | CA2300328A1 Modulating transcription of genes in vascular cells |
| 03/13/2001 | US6201169 Transgenic brassica plant; stable integration and under control of expression signals; produced by contacting exogenous dna with plant protoplast using polyethylene glycol treatment, electroporation, and/or heat shock |
| 03/13/2001 | US6201168 Transgenic knockout mouse whose genome has homozygous disruption in endogenous beta-sarcoglycan gene; drug screening for treatments of muscular dystrophies and ischemic injuries; antiischemic agents |
| 03/13/2001 | US6201167 Producing transgenic mouse whose genome includes expression system of a promoter, a signal sequence and a dna sequence encoding the desired protein; then collecting semen |
| 03/13/2001 | US6201166 Transgenic mouse hepatitis C virus model comprising a hepatitis C viral fragment |
| 03/13/2001 | US6201165 Drug screening by contacting isolated cardiomyocyte having calcineurin, calcium calmodulin dependent kinase iv or ii alpha, p38, or mkk6 transgene with compound; measuring physiological parameter; and comparing to control |
| 03/13/2001 | US6201115 Amplifying sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells therapeutic and vaccine applications |
| 03/13/2001 | US6201113 Dna of a primer and a dnazyme-encoding zymogene; detection and quantitation of target nucleic acid sequence in a sample |
| 03/13/2001 | US6201111 Methods for treating subjects with disorders characterized by expression of tumor rejection antigen precursors |
| 03/13/2001 | US6201108 Antibodies which bind to mammalian transforming growth factor-beta type ii receptor; treatment of bone disorders; anticarcinogenic/antimetastasis agents |
| 03/13/2001 | US6201107 Cystic fibrosis gene |
| 03/13/2001 | US6201106 Cytokine signal regulators |